Polystyrene microplastic induced airway hyper-responsiveness, and pulmonary inflammation are mitigated by bronchom treatment in murine model of lung disease

Microplastics are global menace-associated with respiratory damages. The objective of this study was to investigate the airway hyper-responsiveness (AHR) and inflammation induced by polystyrene microplastic (PSMPs) in male C57BL/6 mice and its modulation by 'Bronchom', an herbal medicine. For the study, animals were pre-treated with varying doses of Bronchom before 21-day exposure to PSMPs, followed by assessment of pulmonary damages. PSMPs exposure in mice significantly induced AHR to methacholine, represented by elevated respiratory resistance, and reduced lung compliance. PSMPs also induced influx of pro-inflammatory cells and release of pro-inflammatory mediators TNF-α, IL-1β, IL-5, IL-6 and MIP-2α in the bronchoalveolar lavage of PSMPs-exposed animals. Histopathological analysis confirmed leukocyte infiltration and mild fibrosis in the lung tissues of PSMPs-exposed animals. PSMPs-exposure also enhanced mRNA expression of pro-inflammatory biomarkers in lung tissues. Bronchom-treated mice showed significant protection against the PSMPs-induced AHR, inflammatory cell influx and cytokine expression, along with histopathological changes in dose-dependent manner. Pirfenidone used as a positive control showed beneficiary effects against PSMPs-induced respiratory distress. Interestingly, FTIR spectroscopy of the Bronchom-treated mice lung tissues indicated dose-dependent reduction in PSMPs-specific transmittance signatures, suggesting their reduced bioaccumulation. In human THP-1 macrophages, Bronchom also attenuated PSMPs-induced TNF-α and IL-6 cytokines release. Ultra-high-performance-liquid-chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QToF-MS) identified 80 phytochemicals, associated with robust anti-inflammatory and anti-oxidant profile. These results indicated that Bronchom effectively mitigates PSMPs-induced respiratory distress-associated inflammation and PSMPs bioaccumulation in lung tissue, likely due to its rich phytochemical composition. This study highlights Bronchom as a promising herbal intervention against microplastic-associated pulmonary ailments.

Authors

Institutions

Publication Details

Journal
Biomedicine & Pharmacotherapy
Published
2025-05-02
DOI
https://doi.org/10.1016/j.biopha.2025.118122
Citations
5
Primary Topic
Antimicrobial agents and applications
Type
article
Field-Weighted Citation Impact
4.68
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polystyrene microplastic induced airway hyper-responsiveness, and pulmonary inflammation are mitigated by bronchom treatment in murine model of lung disease

Aakanksha Tiwari, Rishabh Dev, Vivek Gohel, Anurag Varshney et al.
5 citations
Biomedicine & Pharmacotherapy
Antimicrobial agents and applications
4.68
article

Polystyrene microplastic induced airway hyper-responsiveness, and pulmonary inflammation are mitigated by bronchom treatment in murine model of lung disease

Aakanksha Tiwari, Rishabh Dev, Vivek Gohel, Anurag Varshney, Acharya Balkrishna, Kunal Bhattacharya, Sandeep Sinha, Ankita Kumari
article en
5 citations

Abstract

Microplastics are global menace-associated with respiratory damages. The objective of this study was to investigate the airway hyper-responsiveness (AHR) and inflammation induced by polystyrene microplastic (PSMPs) in male C57BL/6 mice and its modulation by 'Bronchom', an herbal medicine. For the study, animals were pre-treated with varying doses of Bronchom before 21-day exposure to PSMPs, followed by assessment of pulmonary damages. PSMPs exposure in mice significantly induced AHR to methacholine, represented by elevated respiratory resistance, and reduced lung compliance. PSMPs also induced influx of pro-inflammatory cells and release of pro-inflammatory mediators TNF-α, IL-1β, IL-5, IL-6 and MIP-2α in the bronchoalveolar lavage of PSMPs-exposed animals. Histopathological analysis confirmed leukocyte infiltration and mild fibrosis in the lung tissues of PSMPs-exposed animals. PSMPs-exposure also enhanced mRNA expression of pro-inflammatory biomarkers in lung tissues. Bronchom-treated mice showed significant protection against the PSMPs-induced AHR, inflammatory cell influx and cytokine expression, along with histopathological changes in dose-dependent manner. Pirfenidone used as a positive control showed beneficiary effects against PSMPs-induced respiratory distress. Interestingly, FTIR spectroscopy of the Bronchom-treated mice lung tissues indicated dose-dependent reduction in PSMPs-specific transmittance signatures, suggesting their reduced bioaccumulation. In human THP-1 macrophages, Bronchom also attenuated PSMPs-induced TNF-α and IL-6 cytokines release. Ultra-high-performance-liquid-chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QToF-MS) identified 80 phytochemicals, associated with robust anti-inflammatory and anti-oxidant profile. These results indicated that Bronchom effectively mitigates PSMPs-induced respiratory distress-associated inflammation and PSMPs bioaccumulation in lung tissue, likely due to its rich phytochemical composition. This study highlights Bronchom as a promising herbal intervention against microplastic-associated pulmonary ailments.

Biomedicine & PharmacotherapyVol. 187
Patanjali Research Foundation (IN)
Good health and well-being
Openalex Percentile: Top 6%
Antimicrobial agents and applications
4.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.